Literature DB >> 17521166

Analytical profiling of biosynthetic intermediates involved in the gentamicin pathway of Micromonospora echinospora by high-performance liquid chromatography using electrospray ionization mass spectrometric detection.

Je Won Park1, Jay Sung Joong Hong, Niranjan Parajuli, Hwa Soo Koh, Sung Ryeol Park, Mi-Ok Lee, Si-Kyu Lim, Yeo Joon Yoon.   

Abstract

In the present study, we developed a sensitive and highly selective method of detecting the biosynthetic intermediates involved in the gentamicin pathway from a cell culture of Micromonospora echinospora. A novel extraction method utilizing a dual solid-phase extraction (SPE) technique was employed to purify and recover all of the gentamicin-related components from the cell culture broth, and high-performance liquid chromatography (HPLC) coupled with electrospray ionization mass spectrometry (ESI-MS/MS) was used to analyze the extractant for gentamicin intermediates. The pH of the culture broth was adjusted to an acidic condition of pH 2 prior to the extraction. The samples were first cleaned with a reversed-phase AccuBOND C(18) cartridge, and then the aminoglycosidic components were purified using a cationic exchanger OASIS MCX cartridge. The detection limit of a gentamicin standard spiked in blank medium processed by this method was found to be approximately 5 ng for each component of the gentamicin C complex, and the mean recovery for each component of standard gentamicin was above 91% when analyzed by HPLC-ESI-MS/MS. We further demonstrated that this method enables the analytical profiling of the gentamicin-related compounds produced by wild-type M. echinospora ATCC 15835, which mainly produces the gentamicin C complex, and the UV-induced mutant strain KCTC 10506BP, which produces gentamicin B as the major product. Seven intermediates (paromamine, gentamicin A2, B, X2, A, JI-20A, and JI-20B) besides the gentamicin C complex were detected in the culture broth of both M. echinospora strains when analyzed by MS/MS for the distinct fragmentation patterns of each gentamicin component. This report displays the first example of the HPLC profiling in a wide range of structurally related biosynthetic intermediates involved in the gentamicin pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521166     DOI: 10.1021/ac070028u

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  5 in total

Review 1.  Radical SAM enzymes in the biosynthesis of sugar-containing natural products.

Authors:  Mark W Ruszczycky; Yasushi Ogasawara; Hung-Wen Liu
Journal:  Biochim Biophys Acta       Date:  2011-12-07

2.  Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set.

Authors:  Je Won Park; Jay Sung Joong Hong; Niranjan Parajuli; Won Seok Jung; Sung Ryeol Park; Si-Kyu Lim; Jae Kyung Sohng; Yeo Joon Yoon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-12       Impact factor: 11.205

3.  LC-MS/MS method for simultaneous quantification of dexamethasone and tobramycin in rabbit ocular biofluids.

Authors:  Tuo Meng; Leon Kosmider; Guihong Chai; Aji Alex Moothedathu Raynold; Adam C Pearcy; Bin Qin; Yan Wang; Xiuling Lu; Matthew S Halquist; Qingguo Xu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2021-03-01       Impact factor: 3.205

4.  Exclusive Production of Gentamicin C1a from Micromonospora purpurea by Metabolic Engineering.

Authors:  Zeng Wei; Xianai Shi; Rong Lian; Weibin Wang; Wenrong Hong; Shaobin Guo
Journal:  Antibiotics (Basel)       Date:  2019-12-14

5.  Complete reconstitution of the diverse pathways of gentamicin B biosynthesis.

Authors:  Yeon Hee Ban; Myoung Chong Song; Jae-Yeon Hwang; Hea-Lyung Shin; Hak Joong Kim; Seung Kon Hong; Na Joon Lee; Je Won Park; Sun-Shin Cha; Hung-Wen Liu; Yeo Joon Yoon
Journal:  Nat Chem Biol       Date:  2019-01-14       Impact factor: 15.040

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.